Search

everythinglearnresearchcommunity

for

Search:↓

Recent discoveries have improved our understanding of hair loss, but challenges in treatment and knowledge among specialists still exist.

Leprosy and psoriasis were historically confused, but were finally distinguished as separate diseases in the 1800s.

Rosella C. believes an earlier diagnosis of Cushing disease could have prevented severe symptoms.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Older adults still engage in sexual activities but face challenges like health issues and lack of professional support, highlighting the need for better healthcare provider education and research on sexual fulfillment in old age.

The document concludes that awareness and understanding of hidradenitis suppurativa are increasing, but effective treatments are still needed.

Wigs are still a popular solution for hair loss to maintain a youthful look.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Genetically repaired stem cells may treat certain genetic diseases, Th17 cells are key in fighting systemic fungal infections, hair loss in AGA is due to progenitor cell loss, and α-synuclein transfer might contribute to Parkinson's disease progression.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

The document suggests a possible link between Crohn's disease and Johne's disease and calls for more research.

Thyroid hormones are important for skin health and might help treat skin diseases, but more research is needed to understand their effects fully.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

Six months after COVID-19, most patients still had autoantibodies.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Significant progress was made in understanding PXE, but effective treatments are still needed.

Elastin staining helps assess late-stage scarring alopecia but is not definitive, and clinical diagnosis is still crucial.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

Fibrosing alopecia in a pattern distribution is a new type of scarring hair loss that resembles common baldness and an autoimmune skin disease.

The document says to treat cat fungal infections with medicine and clean the environment, noting that cats without symptoms can still spread it to humans.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Disruptions in sleep-wake cycles can cause health problems like mental, metabolic, and heart diseases, and cancer.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Mesotherapy and platelet-rich plasma treatments may help with hair loss, but their safety and effectiveness are still uncertain.

AI is revolutionizing healthcare by improving diagnosis, treatment, and monitoring, but still needs close supervision.